News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
RTI Biologics Announces 2008 Second Quarter Results
July 24, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading processor of orthopedic and other biologic implants, reported operating results for the quarter ended June 30, 2008 as follows:
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Drug pricing
With MFN now embedded in pharma, execs see little impact from Democrats’ blue wave
November 4, 2026
·
4 min read
·
Annalee Armstrong
Weight loss
Novo, Lilly battle for oral GLP-1 dominance with data tit for tat
November 4, 2026
·
3 min read
·
Annalee Armstrong
Vaccines
Pfizer eyes Europe first for Lyme vaccine as prevalence rises in US
November 4, 2026
·
1 min read
·
Annalee Armstrong
Podcast
Q3 earnings roll on, FDA pushes rare disease, uniQure’s Huntington’s therapy reaches review
November 4, 2026
·
1 min read
·
Jef Akst
